- Booz Allen Hamilton Holding Corp BAH has won a position on the Biomedical Information Technology, Software Development, and Informatics Support (BITSDIS) contract.
- BITSDIS is a five-year IDIQ contract worth up to $350 million to support the National Institutes of Health (NIH) National Cancer Institute (NCI) Center for Biomedical Informatics and Information Technology (CBIIT).
- As a part of this IDIQ, Booz Allen has secured a $29.9 million task order to support the evolving needs of the cancer research community.
- Under the Clinical Trials Reporting Program (CTRP) task order, Booz Allen will provide the complete range of software development, system engineering, and operational support.
- Price Action: BAH shares are trading lower by 2.33% at $77.97 on the last check Tuesday.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
